Laxai Life Sciences Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 32.00 Cr
as on 13-06-2024
- Paid Up Capital ₹ 27.79 Cr
as on 13-06-2024
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 25.40 Cr
as on 13-06-2024
- Satisfied Charges ₹ 164.23 Cr
as on 13-06-2024
- Revenue 12.45%
(FY 2022)
- Profit -4.70%
(FY 2022)
- Ebitda 8.33%
(FY 2022)
- Net Worth -3.83%
(FY 2022)
- Total Assets -6.59%
(FY 2022)
About Laxai Life Sciences
The Corporate was formerly known as Laxai - Avanti Life - Sciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 32.00 Cr and a paid-up capital of Rs 27.79 Cr.
The company currently has active open charges totaling ₹25.40 Cr. The company has closed loans amounting to ₹164.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Laxai Life Sciences Private Limited India is Preeti Agarwal as COMPANY SECRETARY. Lavanya Gali, Nagajayanthi Juttur, and Nikhil Puri serve as directors at the Company.
- CIN/LLPIN
U24119TG2006PTC050583
- Company No.
050583
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2006
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Laxai Life Sciences?
Executive Team (1)
PA
Preeti Agarwal Company SecretaryAppointment Date: 21-Jun-2023
Status: Current
Board Members(3)
Financial Performance and Corporate Structure Insights of Laxai Life Sciences.
Laxai Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.45% increase. The company also saw a slight decrease in profitability, with a 4.7% decrease in profit. The company's net worth dipped by a decrease of 3.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Laxai Life Sciences?
In 2022, Laxai Life Sciences had a promoter holding of 54.54% and a public holding of 45.46%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Laxai Biopharma Private Limited
Active
9 years 2 months Lavanya Gali and Nagajayanthi Juttur are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Mar 2024 | ₹25.00 Cr | Open |
Hdfc Bank Limited Creation Date: 11 Dec 2023 | ₹4.00 M | Open |
Others Creation Date: 29 Apr 2020 | ₹3.00 M | Satisfied |
How Many Employees Work at Laxai Life Sciences?
Laxai Life Sciences has a workforce of 345 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Sep 30, 2022, Laxai Life Sciences has raised a total of ₹ 211.84 Cr, with the most recent deal valued at ₹ 140 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
